Evidence map›Paper›PMID 30805082›Full record

ArticleOxidative medicine and cellular longevity2019

Purple Sweet Potato Color Attenuates Kidney Damage by Blocking VEGFR2/ROS/NLRP3 Signaling in High-Fat Diet-Treated Mice.

Gui-Hong Zheng, Qun Shan, Jing-Jing Mu, Yong-Jian Wang, Zi-Feng Zhang, Shao-Hua Fan, Bin Hu, Meng-Qiu Li, Jun Xie, Ping Chen and 3 more

RetractedOpen access · hybridAbstract readRetracted Publication
In one paragraph

Article in Oxidative medicine and cellular longevity, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Monkfish (Molecules (Basel, Switzerland) · 2022
    Article
  5. Alveolar Type II Cell Damage and Nrf2-SOD1 Pathway Downregulation Are Involved in PMInternational journal of environmental research and public health · 2022
    Article
  6. Sweet Potato (Foods (Basel, Switzerland) · 2022
    Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Gui-Hong ZhengKey Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou, 221116 Jiangsu Province, China.ORCID 0000-0002-0334-0209
Qun ShanKey Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou, 221116 Jiangsu Province, China.ORCID 0000-0002-2337-7295
Jing-Jing MuKey Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou, 221116 Jiangsu Province, China.
Yong-Jian WangKey Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou, 221116 Jiangsu Province, China.
Zi-Feng ZhangKey Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou, 221116 Jiangsu Province, China.
Shao-Hua FanKey Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou, 221116 Jiangsu Province, China.
Bin HuKey Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou, 221116 Jiangsu Province, China.
Meng-Qiu LiKey Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou, 221116 Jiangsu Province, China.
Jun XieKey Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou, 221116 Jiangsu Province, China.
Ping ChenKey Laboratory of Biology and Genetic Improvement of Sweet Potato, Ministry of Agriculture, Jiangsu Xuzhou Sweet Potato Research Center, Xuzhou, 221131 Jiangsu Province, China.
Dong-Mei WuKey Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou, 221116 Jiangsu Province, China.ORCID 0000-0003-4850-3697
Jun LuKey Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou, 221116 Jiangsu Province, China.ORCID 0000-0002-2801-5330
Yuan-Lin ZhengKey Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou, 221116 Jiangsu Province, China.ORCID 0000-0003-1754-0508
Jiangsu Normal University · CNSweet Potato Research Institute · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Our preliminary data showed that VEGFR2 upregulation promoted renal ROS overproduction in high-fat diet- (HFD-) treated mice. Given that ROS-induced NLRP3 activation plays a central role in the pathogenesis of type 2 diabetic kidney injury, we evaluate whether VEGFR2 upregulation induces type 2 diabetic kidney injury via ROS-mediated NLRP3 activation and further explore the underlying mechanism. Our results showed that VEGFR2 knockdown decreased ROS overproduction, blocked NLRP3-dependent inflammation, and alleviated kidney damage in HFD-treated mice. Treatment with

Indexed as

Signal TransductionAnimalsDiet, High-FatGene Knockdown TechniquesInflammationIpomoea batatasKidneyMaleMice, Inbred ICRNLR Family, Pyrin Domain-Containing 3 ProteinOrgan SpecificityOxidative StressPigments, BiologicalReactive Oxygen SpeciesThioctic AcidVascular Endothelial Growth Factor Receptor-2NLR Family, Pyrin Domain-Containing 3 ProteinPigments, BiologicalReactive Oxygen SpeciesThioctic AcidVascular Endothelial Growth Factor Receptor-2

Identifiers

PMID30805082
PMCPMC6360596
OpenAlexW2910476797

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.